See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: June 23, 2006

Sinus Infections Bladder Disorders Venous Leg Ulcers

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Sinus Infections

This clinical research study will evaluate a treatment for acute sinusitis. You may qualify if you have had the following symptoms for seven days: frontal headache, nasal discharge, fever, or facial pain or tenderness. Study-related evaluations, procedures, x-ray, and lab work will be provided.

The research site is in Portage, Mich.

More information

Please see


Bladder Disorders

The study involves injecting an investigational medication (not yet approved by the FDA) into your bladder muscles to reduce incontinence due to idiopathic overactive bladder. Candidates may qualify if they are 18-80, diagnosed with overactive bladder at least six months, weigh a minimum of 110 pounds, and have not used BOTOX or any other botulinum toxin for any reason. Volunteers also cannot be using clean intermittent catheterization (CIC) to manage urinary incontinence.

The research site is in Los Angeles, Calif.

More information

Please see


Venous Leg Ulcers

This study will evaluate the safety and efficacy of ICXP007 in people undergoing standardized four-layer bandage compression therapy for chronic venous leg ulcer. Volunteers may be included who are at least 18, have an Ankle Brachial Pressure Index of greater than or equal to 0.8 measured by Doppler sonograph, and who do not have exposed bone, tendon or fascia visible around the wound.

Research sites are located in the United States, Canada, and the United Kingdom.

More information

Please see


Copyright 2006 Thomson CenterWatch. All rights reserved.

Consumer News


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.